TickerFacts.

Vaxart, Inc. (VXRT): Capital Expenditures

Annual figures by period end, from SEC filings.

$145.0K
Year ended 2025-12-31
$601.0K
Trailing 12 months to 2026-06-30
-75.3%
3-year compound annual growth
-34.7%
5-year compound annual growth
$9.60M2009-12-26: $4.0K2011-06-30: $700.0K2012-06-30: $1.30M2013-06-30: $1.00M2014-06-30: $100.0K2015-06-30: $100.0K2016-06-30: $200.0K2017-12-31: $117.0K2018-12-31: $707.0K2019-12-31: $850.0K2020-12-31: $1.22M2021-12-31: $5.16M2022-12-31: $9.60M2023-12-31: $1.87M2024-12-31: $554.0K2025-12-31: $145.0K$145.0K
2009-12-26 Capital Expenditures (USD) 2025-12-31
Period endedCapital ExpendituresChange YoYSource filing
2025-12-31$145.0K-73.8%2026-03-13, From 2025-01-01
2024-12-31$554.0K-70.4%2026-03-13, From 2024-01-01
2023-12-31$1.87M-80.5%2025-03-20, From 2023-01-01
2022-12-31$9.60M+86.2%2024-03-14, From 2022-01-01
2021-12-31$5.16M+321.7%2023-03-15, From 2021-01-01
2020-12-31$1.22M+43.9%2022-02-24, From 2020-01-01
2019-12-31$850.0K+20.2%2022-02-24, From 2019-01-01
2018-12-31$707.0K+504.3%2021-02-25, From 2018-01-01
2017-12-31$117.0Kn/a2019-02-06, From 2017-01-01
No annual figure between 2016-06-30 and 2017-12-31.
2016-06-30$200.0K+100.0%2017-09-01, From 2015-07-01
2015-06-30$100.0K0.0%2016-09-13, From 2014-07-01
2014-06-30$100.0K-90.0%2016-09-13, From 2013-07-01
2013-06-30$1.00M-23.1%2015-09-11, From 2012-07-01
2012-06-30$1.30M+85.7%2014-09-30, From 2011-07-01
2011-06-30$700.0Kn/a2013-09-27, From 2010-07-01
No annual figure between 2009-12-26 and 2011-06-30.
2009-12-26$4.0Kn/a2012-03-14, From 2008-12-28

Capital Expenditures at similar companies

Companies with the same SEC industry code (Biological Products, (No Diagnostic Substances)), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
Vaxart, Inc. (VXRT)2025-12-31$145.0K-73.8%
Iovance Biotherapeutics, Inc. (IOVA)2025-12-31$33.84M+205.7%
Vericel Corp (VCEL)2025-12-31$27.16M-57.5%
Adaptive Biotechnologies Corp (ADPT)2025-12-31$2.96M-19.2%
Adaptimmune Therapeutics PLC (ADAPY)2024-12-31$886.0K-81.1%
REGENXBIO Inc. (RGNX)2025-12-31$2.41M-0.9%
Ginkgo Bioworks Holdings, Inc. (DNA)2025-12-31$7.67M-87.7%
Twist Bioscience Corp (TWST)2025-09-30$28.00M+451.7%
Krystal Biotech, Inc. (KRYS)2025-12-31$11.95M+182.0%

Compare VXRT, IOVA, VCEL, ADPT side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗